ARC Announce New Partnership with Wasson-ECE
Activated Research Company (ARC), producers of the Polyarc reactor, has announced a new partnership with Wasson-ECE to bring the system to the international market for the first time.
Activated Research Company (ARC) (Minnesota, USA), producers of the Polyarc reactor, has announced a new partnership with Wasson-ECE (Colorado, USA) to bring the system to the international market for the first time.
The Polyarc reactor is a catalytic microreactor designed to enhance gas chromatography (GC) with a flame ionization detector (FID) by converting organic compounds to methane prior to detection. A recent publication in The Analyst demonstrated the reaction of trimethylsilylated chemical analytes to methane using this system (1).
“Combining our private label version of the Polyarc reactor system with our core chromatography technology allows us to expand our portfolio of solutions, which will greatly benefit our customers,” said John Wasson, President of Wasson-ECE. “There are many applications of the device and we look forward to integrating it into new and existing GC solutions as well as being ARC’s global distribution channel,” he continued.
This collaboration sees Wasson-ECE become the distributor for this catalytic microreactor outside of the US as well as providing technical assistance.
For more information please visit www.activatedresearch.com and www.wassonece.com
Reference
- C. Beach et al., Analyst141, 1627–1632 (2016).
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
